Literature DB >> 8476569

Regulation of lymphocyte function by protein phosphorylation.

R M Perlmutter1, S D Levin, M W Appleby, S J Anderson, J Alberola-Ila.   

Abstract

Variations in protein phosphorylation provide the predominant means of enzymatic regulation now known in biological systems, especially in the regulation of signal transduction from cell surface receptors. Analysis of these signaling pathways has proceeded especially rapidly in lymphocytes, in part because these cells can be isolated with relative ease and can in many cases be maintained in vitro for prolonged periods as clonal populations. During the past few years, both biochemical and genetic evidence has been adduced indicating that the antigen receptors of T and B lymphocytes associate functionally with nonreceptor protein tyrosine kinases. Similar data implicate protein tyrosine kinases in signaling from the CD4 and CD8 coreceptors and the beta chain of the IL-2 receptor. Protein serine/threonine kinases and several different phosphatases also participate in the intracellular propagation of antigen receptor-derived signals. Here we review the lymphocyte surface receptors that are believed to act by altering protein phosphorylation, the kinases and phosphatases that are believed to regulate signal transduction in lymphocytes, and the implications of these results for the broader study of cell signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476569     DOI: 10.1146/annurev.iy.11.040193.002315

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  50 in total

1.  Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.

Authors:  M Hegen; J Kameoka; R P Dong; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Navigating the leukocyte signaling maze guided by Ariadne's thread.

Authors:  Amnon Altman; Gary A Koretzky; Constantine D Tsoukas
Journal:  Nat Immunol       Date:  2009-11       Impact factor: 25.606

4.  Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain.

Authors:  T Furukawa; M Itoh; N X Krueger; M Streuli; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins.

Authors:  J E Hutchcroft; B E Bierer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Discordant phenotype in siblings with X-linked agammaglobulinemia.

Authors:  M J Bykowsky; R N Haire; Y Ohta; H Tang; S S Sung; E S Veksler; J M Greene; S M Fu; G W Litman; K E Sullivan
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.

Authors:  L Racioppi; G Matarese; U D'Oro; M De Pascale; A M Masci; S Fontana; S Zappacosta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling.

Authors:  S Latour; J Zhang; R P Siraganian; A Veillette
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

9.  Interaction of Listeria monocytogenes with mouse dendritic cells.

Authors:  C A Guzman; M Rohde; T Chakraborty; E Domann; M Hudel; J Wehland; K N Timmis
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Developmental regulation of TCR-CD3-dependent [Ca2+]i responses of individual normal and pp59fyn-deficient T lymphocytes.

Authors:  K E Hedin; M W Appleby; D E Clapham
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.